1.gif (1892 bytes)

Brief Reports

Indian Pediatrics 2002; 39:657-659

Exchange Blood Transfusion in Neonatal Hyperbilirubinemia-Role of Calcium

K.K. Locham
Kiranjeet Kaur*
Rajeev Tandon
Manpreet Kaur
Rajinder Garg

From the Departments of Pediatrics and Biochemistry*, Government Medical College, Rajindra Hospital, Patiala 147 001, Punjab, India.

Correspondence to: Dr. K.K. Locham, Professor and Head, Department of Pediatrics, Government Medical College, Rajindra Hospital, Patiala 147 001, Punjab, India.

E-mail: [email protected]

Manuscript received: May 2, 2001;

Initial review completed: June 12, 2001;

Revision accepted: November 23, 2001.

Neonatal jaundice is seen in approximately 80% of preterm and 60% of term babies(1). Whole blood collected in citrate phosphate dextrose (CPD) is preferred for doing exchange, but citrate in CPD binds calcium leading to formation of unionized calcium compound. After injection, the citrate ion is removed from blood within few minutes by the liver and is polymerized into glucose or metabolized directly for energy(2). Administration of calcium gluconate has been reported to interfere with rate of citrate removal from the blood(3). The role of giving extra calcium during exchange transfusion is not clear. The present study was designed to evaluate the need for giving extra calcium during exchange transfusion or not.

Subjects and Methods

The study was conducted on 30 healthy appropriate for gestational age (AGA) babies with neonatal jaundice, requiring exchange blood transfusion as per Cashore and Stern chart(4) and as per recommended indications(5). Patients were allocated alternatively to two groups; namely study group and control group. No specific randomization and blinding was done. Fifteen cases of study group were administered 1ml of 10% calcium gluconate IV for every 100 ml of CPD blood exchanged, while 15 cases of control group were not administered calcium.

Double volume exchange was done in thermoneutral environment using fresh blood containing CPD as anticoagulant. Cardiac monitoring was done during the procedure. Estimation of total and ionized serum calcium and total and differential serum bilirubin were done immediately before the start and after the completion of exchange transfusion.

Serum bilirubin was estimated by method of Malloy and Evelyn(6). Total serum calcium level was estimated by Trinder’s method(7). Ionic calcium was calculated by Zeisler’s method(8).

Results

The mean total serum calcium levels pre and post exchange were 9.57 ± 0.34 mg/dl and 9.76 ± 0.34 mg/dl respectively in the study group. The rise in total calcium levels (post exchange) was significant (p<0.01). In control group, the mean total serum calcium levels, pre and post exchange were 10.12 ± 0.60 mg/dl and 9.85 ± 0.54 mg/dl respectively. There was fall in total serum calcium levels after exchange and this fall was highly significant (p<0.01).

In study group, mean ionized serum calcium levels pre and post exchange were 4.77 ± 0.15 mg/dl and 4.82 ± 0.17 mg/dl, respectively. The rise in ionized calcium levels (post exchange) was significant (p<0.05), whereas in control group there was fall in ionized serum calcium levels (pre exchange = 4.91 ± 0.13 mg/dl and post exchange = 4.74 ± 0.15 mg/dl) which was significant (p<0.001).

There was no documented hypocalcemia in either study or control group. Apnea, hypoglycemia and death was seen in one patient each in study and control groups. However, cardiac arrest was observed in one case of study group only.

Discussion

In present study, although a significant fall in total and ionized calcium levels were observed in the control group after exchange transfusion, these did not result in hypo-calcemia.

In the study group, there was a rise in total and ionized serum calcium (post exchange), but hypercalcemia was not documented, similar to earlier observations(9).

Extremely low calcium levels during exchange transfusion have been observed in some studies(9, 10). Hypocalcemia as a complication has also been reported(11), but it was not observed in our study. The rise in calcium level in study group may be due to exogenously administered calcium.

Bradycardia and wide fluctuations in heart rate are reported following the injections of calcium gluconate(12,13). One neonate in our study group had cardiac arrest. Hypoglycemia, apnea and death were comparable in both the groups. Adminis-tration of calcium gluconate has been reported to interfere with rate of citrate removal from blood(3).

It is concluded that administration of calcium is not required during exchange transfusion. However as the sample size was small and no specific randomization and blinding was done in our study, a larger study is required to confirm our findings.

Contributors: KKL supervized data collection and drafting the manuscript; he will act as the gurantor of the paper. RT and KK collected the data and helped in analysis. MK and RG helped in drafting the paper.

Funding: None.

Competing interests: None stated.

 

Key Messages


• Calcium administration has no role in exchange transfusion.

 

References


1. Stoll BJ, Kliegman RM. Jaundice and hyperbilirubinemia in newborn. In: Nelson Textbook of Pediatrics, 16th edn. Eds. Behrman RE, Kliegman RM, Arvin AM. Philadelphia, W.B. Saunders Company, 2000; p 513-517.

2. Guyton AC, Hall JE. Hemostasis and blood coagulation. In: Textbook of Medical Physiology, 9th edn. Eds. Guyton AC, Hall JE, Philadelphia. W.B. Saunders Company, 1996; pp 471-472.

3. Wexler IB, Picnus JB, Natelson S, Lugoroy JK. The fate of citrate in erythroblastotic infants treated with exchange transfusion. J Clinic Invest 1949; 28: 474-478.

4. Cashore WJ, Stern L. The management of hyperblirubinemia. Clin Perinat 1984; 11: 339-344.

5. Hinkes MT, Cloherty JP. Neonatal hyperbilirubinemia. In: Manual of Neonatal Care, 4th edn. Eds. Cloherty JP, Stark AR. Philadelphia, Lippincott Raven Publisher, 1998; pp 175-209.

6. Malloy HT, Eveluyun KA. Test in liver and biliary tract disease. In: Practical Clinical Biochemistry, 4th edn. Ed. Varley H. New Delhi, C.B.S. Publications, 1988; pp 353-355.

7. Trinder P. Electrolytes. In: Microanalysis in Medical Biochemistry, 5th edn. Ed. Wootton IDP. Edinburgh, Churchill Livingstone, 1974; p 68.

8. Zeisler EB. Inorganic ions. In: Clinical Chemistry: Principles and Technics, 2nd edn. Eds. Henry RJ, Cannon DC, Winkelmen JW. Maryland, Harper Row. 1974; pp 664-754.

9. Gershanik JJ, Levkoff AH, Duncan R. Serum ionized value in relation to exchange transfusion. J Pediatr 1973; 83: 847-850.

10. Nelson N, Finnstrom O. Blood exchange transfusions in newborns: the effect on serum ionized calcium. Early Human Dev 1988; 18: 157-164.

11. Jackson JC. Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics 1999; 99: e7.

12. Gill P, Singh M. Experience with exchange transfusion in the newborn. Indian Pediatr 1974; 11: 736-737.

13. Kennan WJ, Novak KK, Southerland JM. Morbidity and mortality associated with exchange transfusion. Pediatrics 1985; 75(Suppl): 417-421.

Home

Past Issue

About IP

About IAP

Feedback

Links

 Author Info.

  Subscription